June 30, 2025 · Form 4 insider transaction
Espinoza Octavio bought 224 shares of Ligand Pharmaceuticals Incorporated at $91.08 per share, a transaction worth $20.4K. The trade was recorded as j and disclosed on an SEC Form 4, filed 2 days after the transaction.
These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).